JP2014531417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014531417A5 JP2014531417A5 JP2014527635A JP2014527635A JP2014531417A5 JP 2014531417 A5 JP2014531417 A5 JP 2014531417A5 JP 2014527635 A JP2014527635 A JP 2014527635A JP 2014527635 A JP2014527635 A JP 2014527635A JP 2014531417 A5 JP2014531417 A5 JP 2014531417A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- ring
- alkyl
- och
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *1SC1C(*1)=NC2C1CC*C2 Chemical compound *1SC1C(*1)=NC2C1CC*C2 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011111991A DE102011111991A1 (de) | 2011-08-30 | 2011-08-30 | Neue Cyclosporin-Derivate |
| DE102011111991.8 | 2011-08-30 | ||
| PCT/EP2012/066726 WO2013030208A1 (de) | 2011-08-30 | 2012-08-29 | Cyclosporin-derivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014531417A JP2014531417A (ja) | 2014-11-27 |
| JP2014531417A5 true JP2014531417A5 (cg-RX-API-DMAC7.html) | 2017-01-19 |
| JP6240072B2 JP6240072B2 (ja) | 2017-11-29 |
Family
ID=46754993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014527635A Expired - Fee Related JP6240072B2 (ja) | 2011-08-30 | 2012-08-29 | シクロスポリン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9453051B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2751127B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6240072B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN103842372A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012300934B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2845663C (cg-RX-API-DMAC7.html) |
| DE (1) | DE102011111991A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2601029T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013030208A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0737730Y2 (ja) | 1989-10-04 | 1995-08-30 | 横河電機株式会社 | 溶射装置 |
| US9428845B1 (en) | 2010-12-28 | 2016-08-30 | Warp Drive Bio, Inc. | Identifying new therapeutic agents |
| CN104513296B (zh) * | 2013-09-27 | 2018-03-02 | 王喆明 | 一种环肽化合物及其用途 |
| WO2016112295A1 (en) | 2015-01-09 | 2016-07-14 | Warp Drive Bio, Inc. | Compounds that participate in cooperative binding and uses thereof |
| CA3000822A1 (en) * | 2015-10-01 | 2017-04-06 | Warp Drive Bio, Inc. | Methods and reagents for analyzing protein-protein interfaces |
| CA3020594A1 (en) | 2016-04-12 | 2017-10-19 | Warp Drive Bio, Inc. | Compositions and methods for the production of compounds |
| US12594275B2 (en) | 2019-02-07 | 2026-04-07 | The Regents Of The University Of California | Immunophilin binding agents and uses thereof |
| MX2022005359A (es) | 2019-11-04 | 2022-06-02 | Revolution Medicines Inc | Inhibidores de ras. |
| CN121471132A (zh) | 2019-11-04 | 2026-02-06 | 锐新医药公司 | Ras抑制剂 |
| WO2021091956A1 (en) | 2019-11-04 | 2021-05-14 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2021173474A1 (en) * | 2020-02-26 | 2021-09-02 | Bacainn Biotherapeutics, Ltd. | Cyclosporine compositions and methods of use |
| CA3172535A1 (en) * | 2020-03-26 | 2021-09-30 | Ching-Pong Mak | Cyclophilin inhibitors and uses thereof |
| IL301298A (en) | 2020-09-15 | 2023-05-01 | Revolution Medicines Inc | Indole derivatives as RAS inhibitors in cancer therapy |
| WO2022192716A1 (en) * | 2021-03-11 | 2022-09-15 | Massachusetts Institute Of Technology | Small molecule suppressors of apoe gene expression and cerebral vascular amyloid pathology |
| CN112919984B (zh) * | 2021-04-16 | 2022-03-08 | 安徽硒无忧现代农业科技有限公司 | 一种生态化富硒有机营养液及其制备方法 |
| IL308195A (en) | 2021-05-05 | 2024-01-01 | Revolution Medicines Inc | RAS inhibitors for cancer treatment |
| AR127308A1 (es) | 2021-10-08 | 2024-01-10 | Revolution Medicines Inc | Inhibidores ras |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1506200A (en) * | 1975-04-30 | 1978-04-05 | Farmaceutici Italia | Glycosides |
| US4672044A (en) | 1984-08-24 | 1987-06-09 | Scripps Clinic & Research Foundation | Murine monoclonal antibody combining site to human C3b receptor (CR1) |
| GB8426672D0 (en) * | 1984-10-22 | 1984-11-28 | Erba Farmitalia | Pharmaceutical compositions |
| US4798823A (en) * | 1987-06-03 | 1989-01-17 | Merck & Co., Inc. | New cyclosporin analogs with modified "C-9 amino acids" |
| AT401823B (de) | 1993-09-30 | 1996-12-27 | Avl Verbrennungskraft Messtech | Optischer indikator zur bestimmung der aktivität eines ions in einer probe |
| AUPO395396A0 (en) | 1996-12-02 | 1997-01-02 | Fujisawa Pharmaceutical Co., Ltd. | Benzamide derivatives |
| PT848009E (pt) * | 1996-12-16 | 2000-11-30 | Pharmachemie Bv | Processo para a preparacao de epirubicina ou seus sais de adicao de acido a partir de daunorubicina |
| CA2285454A1 (en) | 1997-04-07 | 1998-10-15 | Axys Pharmaceuticals Corporation | Compounds and compositions for treating diseases associated with serine protease, particularly tryptase, activity |
| FR2762843B1 (fr) * | 1997-04-30 | 1999-12-10 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
| DE69832984T2 (de) | 1997-10-08 | 2006-09-21 | Isotechnika, Inc., Edmonton | DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN |
| US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
| WO2000020400A1 (en) | 1998-10-05 | 2000-04-13 | Axys Pharmaceuticals, Inc. | Novel compounds and compositions for treating hepatitis c infections |
| DE19859910C2 (de) | 1998-12-23 | 2001-03-22 | Ratiopharm Gmbh | Orales Arzneimittel |
| IL135884A (en) | 2000-04-30 | 2005-08-31 | Yissum Res Dev Co | Method for measuring non-transferrin bound iron |
| US6596499B2 (en) | 2000-11-30 | 2003-07-22 | The Netherlands Cancer Institute | Membrane molecule indicator compositions and methods |
| US6784156B2 (en) * | 2001-03-05 | 2004-08-31 | Enanta Pharmaceuticals, Inc. | Cyclosporins for the treatment of respiratory diseases |
| WO2003087089A1 (en) | 2002-04-16 | 2003-10-23 | Teijin Limited | Piperidine derivatives having ccr3 antagonism |
| AU2003285958A1 (en) | 2002-10-25 | 2004-05-25 | Genesoft Pharmaceuticals, Inc. | Anti-infective biaryl compounds |
| WO2005004805A2 (en) * | 2003-07-02 | 2005-01-20 | Solux Corporation | Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| US20090099346A1 (en) * | 2003-07-02 | 2009-04-16 | Victor Matvienko | Thermally stable crystalline epirubicin hydrochloride |
| DE10339597A1 (de) | 2003-08-26 | 2005-03-31 | Bayer Technology Services Gmbh | Vorrichtung und Verfahren zum Nachweis biochemischer Aktivität enthaltend Gap Junctions |
| AU2004276337B2 (en) | 2003-09-24 | 2009-11-12 | Methylgene Inc. | Inhibitors of histone deacetylase |
| US7378391B2 (en) * | 2004-09-29 | 2008-05-27 | Amr Technology, Inc. | Cyclosporin alkyne analogues and their pharmaceutical uses |
| US7622583B2 (en) | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
| DE102006038403A1 (de) | 2006-08-17 | 2008-02-21 | Heinrich-Heine-Universität Düsseldorf | Verwendung bestimmter chemischer Verbindungen zur Inhibierung der Peptidyl-Prolyl-cis/trans-Isomeraseaktivität von Cyclophilinen |
| SG144809A1 (en) | 2007-01-11 | 2008-08-28 | Millipore U K Ltd | Benzimidazole compounds and their use as chromatographic ligands |
| PL1990405T3 (pl) * | 2007-05-08 | 2018-01-31 | Provivo Oy | Genetycznie zmodyfikowane szczepy wytwarzające metabolity będące antracyklinami użyteczne jako leki przeciwnowotworowe |
| US20100009390A1 (en) * | 2008-05-09 | 2010-01-14 | The Regents Of The University Of California | Mutant antibodies with high affinity for egfr |
| MX2011001152A (es) | 2008-07-30 | 2011-06-09 | Isotechnika Pharma Inc | Moleculas de analogo de ciclosporina no-inmunesupresoras. |
| DE102008060549A1 (de) | 2008-12-04 | 2010-06-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung |
| US8481483B2 (en) * | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
| DE102009037551A1 (de) | 2009-08-17 | 2011-02-24 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Cyclosporinderivate |
-
2011
- 2011-08-30 DE DE102011111991A patent/DE102011111991A1/de not_active Ceased
-
2012
- 2012-08-29 WO PCT/EP2012/066726 patent/WO2013030208A1/de not_active Ceased
- 2012-08-29 US US14/241,126 patent/US9453051B2/en active Active
- 2012-08-29 CA CA2845663A patent/CA2845663C/en active Active
- 2012-08-29 AU AU2012300934A patent/AU2012300934B2/en not_active Ceased
- 2012-08-29 EP EP12751509.6A patent/EP2751127B1/de active Active
- 2012-08-29 ES ES12751509.6T patent/ES2601029T3/es active Active
- 2012-08-29 JP JP2014527635A patent/JP6240072B2/ja not_active Expired - Fee Related
- 2012-08-29 CN CN201280042682.1A patent/CN103842372A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6240072B2 (ja) | シクロスポリン誘導体 | |
| JP2017517508A5 (cg-RX-API-DMAC7.html) | ||
| JP2018524339A5 (cg-RX-API-DMAC7.html) | ||
| JP2008540389A5 (cg-RX-API-DMAC7.html) | ||
| ES2924058T3 (es) | Polimixinas antimicrobianas para el tratamiento de infecciones bacterianas | |
| TW201107318A (en) | Furazanobenzimidazoles | |
| JP2013540102A5 (cg-RX-API-DMAC7.html) | ||
| PT1965798E (pt) | Antibióticos de monobactama úteis | |
| CN104902895A (zh) | 可用作用于治疗增生性疾病的激酶抑制剂的二氢萘啶和相关化合物 | |
| HRP20130900T1 (hr) | Derivat (aza)indola i njegova uporaba u medicinske svrhe | |
| CA2962922C (en) | Sphingosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders | |
| ES2593275T3 (es) | Compuestos herbicidas | |
| JP2008546770A5 (cg-RX-API-DMAC7.html) | ||
| WO2012150537A2 (es) | Nuevas formas sólidas de antibióticos | |
| JP2018502845A5 (cg-RX-API-DMAC7.html) | ||
| JP2017516821A (ja) | ナフチリジンジオン誘導体 | |
| KR20240136386A (ko) | 대사 및 간 장애 치료를 위한 약학 제제 및 방법 | |
| JP2016529235A5 (cg-RX-API-DMAC7.html) | ||
| JP2025148472A (ja) | 緑膿菌病原性因子LasBの阻害剤 | |
| JP2006502214A5 (cg-RX-API-DMAC7.html) | ||
| ES2544086T3 (es) | Derivados de 2-metoxi-piridin-4-ilo | |
| JP2013544880A5 (cg-RX-API-DMAC7.html) | ||
| CN105616408B (zh) | 吡啶并[3,4-b]吲哚衍生物作为IDO抑制剂的用途 | |
| IL305099A (en) | Small molecule activators of yap transcriptional activity for regenerative organ repair | |
| JP2006523705A5 (cg-RX-API-DMAC7.html) |